LY3437943
The Book of Peptides is not a clinic and not your doctor. We do not sell, prescribe, recommend, or personalize any compound, and no grade or ranking here is an endorsement. In the United States, most of these compounds are not FDA-approved and are sold for laboratory research only; a few are prescription drugs, and some are controlled substances or banned in sport. Possessing or administering an unapproved compound outside an authorized setting may be unlawful. Nothing here is a recommendation to buy, possess, or self-administer anything. Consult a licensed physician before any decision involving peptide use.
The triple agonist (GLP-1/GIP/glucagon) from Eli Lilly's TRIUMPH Phase 3 program – the most-searched investigational weight-loss compound in this book, and the one most likely to draw a real prescription eventually. TRIUMPH-4 reported 28.7% mean weight loss at the 12 mg dose, the largest ever recorded in a Phase 3 obesity trial to any drug, alongside real relief from osteoarthritis pain in the same program.
